Our latest COVID-19 information - full Autumn programme of webinars now in place

Borderlines between Medicines and Food Training Course

This seminar aims to assist delegates to an understanding of how the borderline between medicines and foods may be defined and how best to tailor the presentation of their products to the regulatory structure appropriate to them

9 Dec 2021

& 10 Dec 2021

Book now


Course Overview

Medicines treat, cure or prevent illness. Foods provide nutrition. But are the distinctions so clear?

Foods also have a physiological effect and a role in disease risk reduction – and substances whose purpose is nutritional may be presented as medicines. An understanding of where the borderline lies between medicines and foods is essential for the successful marketing of specialist health products: getting it wrong is a costly route to market failure. However,the regulatory framework is detailed and complex, requiring a knowledge of the relevant legislation.

This seminar will highlight the most important regulatory issues, with particular focus on the borderline between botanical food supplements and herbal medicinal products, and on health claims and the long outstanding question of what the authorisation process for botanical claims will be.

Why you should attend

Topics to be covered at this seminar:

  • Where the borderline lies and on which side your product fits
  • Comply with medicines legislation and the European Directive on Traditional Herbal Medicinal Products
  • Understand and learn how to work with the Nutrition and Health Claims Regulation
  • Discuss the future for botanical claims with industry experts
  • Learn about the health claims in Europe and the implications for marketing and research and development strategies
  • Master the key aspects of EU borderline law

Book now

Book now

9 Dec 2021
Face-to-face, (venue not yet confirmed)
9 Dec 2021
(venue not yet confirmed)
GBP 599.00
EUR 839.00
USD 934.00
Until 28 Oct 21*
Enrol now
to attend
(venue not yet confirmed)
  • 1 day of classroom-based training
  • Meet presenters and fellow attendees in person
  • Lunch and refreshments provided
  • Download documentation and certification of completion
  • Fair transfer and cancellation policy
10 Dec 2021
Live webinar
10 Dec 2021
Live webinar
GBP 499.00
EUR 719.00
USD 814.00
Until 29 Oct 21*
Enrol now
to attend
Live webinar

Learn more about our face-to-face and webinar training formats.

* Note the early booking discount cannot be combined with any other offers or promotional code

Customised in-house training

We can customise this course to meet the requirements of your organisation and deliver it at your location and/or online.

Contact us

You may also be interested in

Previous customers include...

  • A Nelson & Co Limited
  • Bayer Consumer Care AG
  • Body Shop International plc
  • Boehringer Ingelheim Ltd
  • Boots UK Ltd
  • Charles River Laboratories
  • Di Renzo SRL
  • Dr Willmar Schwabe GmbH & Co
  • EuroCaps Limited
  • Finnish Food Safety Authority Evira
  • Health Products Regulatory Authority
  • Helsinn Healthcare SA
  • Johnson & Johnson Consumer Services EAME Ltd
  • Kinesis Pharma BV
  • Lifes2good
  • Meda Pharmaceuticals Limited
  • Morinda UK Ltd
  • Newtricious R & D
  • Nutri Imports & Exports Ltd
  • Oriol Cerda Alimbau
  • Pliva Croatia Ltd
  • Pliva Hrvatska d.o.o.
  • Reckitt Benckiser Healthcare (UK) Ltd
  • Solgar UK Ltd
  • State Agency of Medicines
  • Thornton & Ross Ltd
  • Unilever Plc
  • University of Chester
  • Zentiva ks

A really good and useful course. The speakers are obviously experts in their fields and are very good at communicating their knowledge.

Miriam Ferrer, Head of New Product Development, Cambridge Nutraceuticals, Dec 19

Very worthwhile course with a great mix of experts.

Stephanie Ward, Marketing Executive, Cambridge Nutraceuticals, Dec 19

A good course.

Konstantina Karagkika, Technical Manager, Innocent Drinks, Dec 19

Overall it was informative, content was fine

Sorwar Choudhury, Head of Medical, Pharmacovigilance and Regulatory Affairs, Meda Pharmaceuticals Limited, Dec 16